{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:30:04Z","timestamp":1791009004616,"version":"4.1.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,8,11]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>High sIgM level is a potential key factor associated with poorer clinical outcome in CLL. Genetic and epigenetic features influence sIgM levels and function in CLL.<\/jats:p>","DOI":"10.1182\/blood-2016-03-707786","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T09:25:18Z","timestamp":1465982718000},"page":"816-826","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":56,"title":["Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL"],"prefix":"10.1182","volume":"128","author":[{"given":"Annalisa","family":"D\u2019Avola","sequence":"first","affiliation":[{"name":"Haematology Oncology Group, Cancer Sciences Unit, and"},{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Drennan","sequence":"additional","affiliation":[{"name":"Haematology Oncology Group, Cancer Sciences Unit, and"},{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Tracy","sequence":"additional","affiliation":[{"name":"Haematology Oncology Group, Cancer Sciences Unit, and"},{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isla","family":"Henderson","sequence":"additional","affiliation":[{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Chiecchio","sequence":"additional","affiliation":[{"name":"Wessex Regional Genetics Laboratory, Salisbury National Health Service (NHS) Foundation Trust, Salisbury, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Larrayoz","sequence":"additional","affiliation":[{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"},{"name":"Cancer Genomics Group, Cancer Sciences Unit, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rose-Zerilli","sequence":"additional","affiliation":[{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"},{"name":"Cancer Genomics Group, Cancer Sciences Unit, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Strefford","sequence":"additional","affiliation":[{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"},{"name":"Cancer Genomics Group, Cancer Sciences Unit, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Plass","sequence":"additional","affiliation":[{"name":"Division of Epigenomics and Cancer Risk Factors, The German Cancer Research Center, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"},{"name":"Medical Oncology Department, University Hospital Southampton NHS Trust, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Steele","sequence":"additional","affiliation":[{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Packham","sequence":"additional","affiliation":[{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freda K.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Oakes","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Forconi","sequence":"additional","affiliation":[{"name":"Haematology Oncology Group, Cancer Sciences Unit, and"},{"name":"Cancer Sciences Unit, Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centres, University of Southampton, Southampton, United Kingdom;"},{"name":"Haematology Department, University Hospital Southampton NHS Trust, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2019111905150168400_B1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3324\/haematol.2013.098384","article-title":"The outcome of B-cell receptor signaling in CLL: proliferation or anergy.","volume":"99","author":"Packham","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"2019111905150168400_B2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.seminhematol.2014.05.003","article-title":"The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia.","volume":"51","author":"Stevenson","year":"2014","journal-title":"Semin Hematol"},{"issue":"16","key":"2019111905150168400_B3","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood-2011-06-338855","article-title":"B-cell receptor signaling in chronic lymphocytic leukemia.","volume":"118","author":"Stevenson","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111905150168400_B4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11899-011-0104-z","article-title":"Inhibiting B-cell receptor signaling pathways in chronic lymphocytic leukemia.","volume":"7","author":"Burger","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"issue":"8","key":"2019111905150168400_B5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2013-07-515361","article-title":"Bruton\u2019s tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL).","volume":"123","author":"Woyach","year":"2014","journal-title":"Blood"},{"issue":"13","key":"2019111905150168400_B6","first-page":"1278","article-title":"Ibrutinib in relapsed chronic lymphocytic leukemia.","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111905150168400_B7","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.20120833","article-title":"Cellular origin and pathophysiology of chronic lymphocytic leukemia.","volume":"209","author":"Seifert","year":"2012","journal-title":"J Exp Med"},{"issue":"1","key":"2019111905150168400_B8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2009-06-225813","article-title":"The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL.","volume":"115","author":"Forconi","year":"2010","journal-title":"Blood"},{"key":"2019111905150168400_B9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(01)83004-9","article-title":"The occurrence and significance of V gene mutations in B cell-derived human malignancy.","volume":"83","author":"Stevenson","year":"2001","journal-title":"Adv Cancer Res"},{"issue":"6","key":"2019111905150168400_B10","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2019111905150168400_B11","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"1","key":"2019111905150168400_B12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-065X.2010.00936.x","article-title":"Molecular underpinning of B-cell anergy.","volume":"237","author":"Yarkoni","year":"2010","journal-title":"Immunol Rev"},{"issue":"10","key":"2019111905150168400_B13","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","article-title":"Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status.","volume":"109","author":"Mockridge","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2019111905150168400_B14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","article-title":"Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.","volume":"101","author":"Lanham","year":"2003","journal-title":"Blood"},{"issue":"14","key":"2019111905150168400_B15","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1158\/0008-5472.CAN-06-0085","article-title":"Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression.","volume":"66","author":"Deglesne","year":"2006","journal-title":"Cancer Res"},{"issue":"12","key":"2019111905150168400_B16","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1182\/blood-2004-07-2669","article-title":"Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.","volume":"105","author":"Petlickovski","year":"2005","journal-title":"Blood"},{"issue":"13","key":"2019111905150168400_B17","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","article-title":"Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.","volume":"100","author":"Chen","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2019111905150168400_B18","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.174.6.3749","article-title":"B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.","volume":"174","author":"N\u00e9dellec","year":"2005","journal-title":"J Immunol"},{"issue":"16","key":"2019111905150168400_B19","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1182\/blood-2014-10-606038","article-title":"Three-year follow-up of treatment-na\u00efve and previously treated patients with CLL and SLL receiving single-agent ibrutinib.","volume":"125","author":"Byrd","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2019111905150168400_B20","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2013-09-527853","article-title":"Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy.","volume":"123","author":"Woyach","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2019111905150168400_B21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1182\/blood-2014-02-555722","article-title":"Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.","volume":"124","author":"Claus","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2019111905150168400_B22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2217\/epi.15.6","article-title":"DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.","volume":"7","author":"Wang","year":"2015","journal-title":"Epigenomics"},{"issue":"11","key":"2019111905150168400_B23","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","article-title":"Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.","volume":"44","author":"Kulis","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"2019111905150168400_B24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","article-title":"Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.","volume":"26","author":"Landau","year":"2014","journal-title":"Cancer Cell"},{"issue":"3","key":"2019111905150168400_B25","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/leu.2014.252","article-title":"A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.","volume":"29","author":"Queir\u00f3s","year":"2015","journal-title":"Leukemia"},{"key":"2019111905150168400_B26","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1038\/bcj.2015.14","article-title":"Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.","volume":"5","author":"Smith","year":"2015","journal-title":"Blood Cancer J"},{"issue":"3","key":"2019111905150168400_B27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.3488","article-title":"DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia.","volume":"48","author":"Oakes","year":"2016","journal-title":"Nat Genet"},{"issue":"21","key":"2019111905150168400_B28","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","article-title":"Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.","volume":"123","author":"Stilgenbauer","year":"2014","journal-title":"Blood"},{"issue":"18","key":"2019111905150168400_B29","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2011-11-312421","article-title":"Risk categories and refractory CLL in the era of chemoimmunotherapy.","volume":"119","author":"Zenz","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2019111905150168400_B30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2011.02.002","article-title":"Importance of genetics in chronic lymphocytic leukemia.","volume":"25","author":"Zenz","year":"2011","journal-title":"Blood Rev"},{"issue":"10","key":"2019111905150168400_B31","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1172\/JCI64101","article-title":"Molecular pathogenesis of chronic lymphocytic leukemia.","volume":"122","author":"Gaidano","year":"2012","journal-title":"J Clin Invest"},{"issue":"24","key":"2019111905150168400_B32","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2013-02-486209","article-title":"Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2019111905150168400_B33","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","article-title":"Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"issue":"26","key":"2019111905150168400_B34","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia.","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111905150168400_B35","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","article-title":"V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.","volume":"100","author":"Kr\u00f6ber","year":"2002","journal-title":"Blood"},{"issue":"1","key":"2019111905150168400_B36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111905150168400_B37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/leu.2013.248","article-title":"Clonal evolution in hematological malignancies and therapeutic implications.","volume":"28","author":"Landau","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"2019111905150168400_B38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/bjh.13269","article-title":"Trisomy 12 is associated with an abbreviated redistribution lymphocytosis during treatment with the BTK inhibitor ibrutinib in patients with chronic lymphocytic leukaemia.","volume":"170","author":"Thompson","year":"2015","journal-title":"Br J Haematol"},{"issue":"10","key":"2019111905150168400_B39","first-page":"1640","article-title":"The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.","volume":"8","author":"Matutes","year":"1994","journal-title":"Leukemia"},{"issue":"12","key":"2019111905150168400_B40","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111905150168400_B41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood-2011-07-370403","article-title":"Surface IgM stimulation induces MEK1\/2-dependent MYC expression in chronic lymphocytic leukemia cells.","volume":"119","author":"Krysov","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2019111905150168400_B42","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1182\/blood-2004-03-0950","article-title":"Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch.","volume":"104","author":"Forconi","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111905150168400_B43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","article-title":"The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.","volume":"146","author":"Rossi","year":"2009","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111905150168400_B44","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood.V98.4.1174","article-title":"Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing.","volume":"98","author":"Forconi","year":"2001","journal-title":"Blood"},{"issue":"2","key":"2019111905150168400_B45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","article-title":"Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.","volume":"119","author":"Rossi","year":"2012","journal-title":"Blood"},{"issue":"22","key":"2019111905150168400_B46","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number.","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal Chem"},{"issue":"11","key":"2019111905150168400_B47","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/leu.2013.98","article-title":"Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.","volume":"27","author":"Strefford","year":"2013","journal-title":"Leukemia"},{"issue":"7","key":"2019111905150168400_B48","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1182\/blood-2006-10-051110","article-title":"Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study.","volume":"109","author":"Bomben","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019111905150168400_B49","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2004-07-2606","article-title":"Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene.","volume":"105","author":"Ghia","year":"2005","journal-title":"Blood"},{"issue":"7","key":"2019111905150168400_B50","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood-2005-06-2227","article-title":"Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status.","volume":"107","author":"Thors\u00e9lius","year":"2006","journal-title":"Blood"},{"issue":"15","key":"2019111905150168400_B51","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood-2013-02-485425","article-title":"Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function.","volume":"122","author":"Coelho","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2019111905150168400_B52","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V43.6.789.789","article-title":"Comparison of normal and CLL lymphocyte surface Ig determinants using peroxidase-labeled antibodies. I. Detection and quantitation of light chain determinants.","volume":"43","author":"Ternynck","year":"1974","journal-title":"Blood"},{"issue":"11","key":"2019111905150168400_B53","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1182\/blood.V99.11.4087","article-title":"B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.","volume":"99","author":"Damle","year":"2002","journal-title":"Blood"},{"issue":"9","key":"2019111905150168400_B54","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.188.9.1679","article-title":"Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells.","volume":"188","author":"Klein","year":"1998","journal-title":"J Exp Med"},{"key":"2019111905150168400_B55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02869","article-title":"Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia.","volume":"3","author":"Wang","year":"2014","journal-title":"eLife"},{"issue":"26","key":"2019111905150168400_B56","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2014-01-552307","article-title":"Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.","volume":"123","author":"Riches","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2019111905150168400_B57","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1158\/2159-8290.CD-13-0349","article-title":"Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia.","volume":"4","author":"Oakes","year":"2014","journal-title":"Cancer Discov"},{"issue":"1","key":"2019111905150168400_B58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/leu.2012.245","article-title":"450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.","volume":"27","author":"Cahill","year":"2013","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/6\/816\/1398345\/816.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/6\/816\/1398345\/816.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T05:15:21Z","timestamp":1574140521000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/6\/816\/35774\/Surface-IgM-expression-and-function-are-associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,11]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,8,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-03-707786","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,11]]}}}